The Cancer Treatment Centers at New Jersey Urology offer the most advanced radiation therapy in a safe, state-of-the-art environment for the most effective cancer treatment.
As a leader in the treatment of prostate cancer with over 10,000+ patients, our Cancer Treatment Centers provide advanced scientific research and innovative clinical trials, including immunotherapy prostate cancer clinical research studies.
Our mission is to provide state-of-the-art treatment and compassionate, personalized care as we partner together through every step of our patients’ cancer treatment.
ADVANCED RADIATION TECHNOLOGY
New Jersey Urology Cancer Treatment Centers utilize the RapidArc™ Radiotherapy system. The RapidArc™ system uses new technology that directs an exact dosage of radiation with unsurpassed precision, delivering treatments at up to eight times the speed of conventional radiation systems. The average treatment is over in less than two minutes.
Although RapidArc™ radiation therapy is extremely effective against some cancers, different conditions may require different approaches. Your care team will determine if the RapidArc™ system is the right answer for you.
The principle behind radiation therapy is that while cancer cells reproduce more quickly than healthy cells, cancer cells cannot easily repair themselves, but healthy cells can. Therefore, by directing a concentrated beam of radiation at an afflicted area, we can stop the growth of cancer while minimizing harm to healthy tissue.
The keys to effective radiation treatment are:
- Having a comprehensive radiation plan designed by an experienced physician.
- Precisely targeting the cancerous tissue.
- Keeping treatments brief and frequent to minimize healthy tissue damage.
- Maintaining the precision of your instruments.
The RapidArc™ system represents a significant improvement over conventional radiotherapy systems in terms of precise targeting, exact dosing, and speed of treatment. It is also an “external beam” treatment, which is the least intrusive therapy option for treating cancer.
SpaceOAR hydrogel is an option for men who undergo radiation treatment for prostate cancer. It acts as a spacer providing space between the rectum and the prostate, making it much less likely that the rectum is exposed to radiation. It is injected into place prior to the start of radiation treatment. Patients may be awake or asleep under general anesthesia for the procedure. SpaceOAR hydrogel is minimally invasive, remains stable during radiation therapy and then is gradually absorbed by the body after radiation therapy has been completed.
Dr. Glen Gejerman, Medical Director of Radiation Oncology at New Jersey Urology, spoke with Ed Randall on WFAN Sports Radio to discuss the benefits of using SpaceOAR hydrogel during prostate cancer treatment.
Mr. Michael Secli, a prostate cancer survivor, describes his journey through radiation treatment along with participating in an immunotherapy clinical trial – all provided through New Jersey Urology’s state-of-the-art advanced Cancer Treatment Center. Hear from his urologic oncologist, Dr. Glen Gejerman, as he explains the treatment options and the science behind immunotherapy treatment.